Log In
Print this Print this

Tedopi (OSE 2101) (formerly EP-2101, EP2101, IDM-2101, Texopi)

  Manage Alerts
Collapse Summary General Information
Company Orphan Synergy Europe-Pharma S.A.
DescriptionVaccine containing 9 modified epitopes plus the PADRE universal helper T lymphocyte epitope targeting 5 tumor-associated antigens (TAA)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today